Jaguar Health, Inc. (JAGX)
Last updated: 2026-10-22 07:18:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Jaguar Health, Inc. (JAGX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.27, with a market capitalization of $5.12M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.25 to $1,118.25. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$5.12M | |
$2.58 | |
$1,313,490,937,500.00 | |
$2.25 | |
$2.63 | |
476.43K | |
2.13M | |
-- | |
$1,118.25 | |
$2.25 | |
-- | |
-- |
Jaguar Health, Inc. (JAGX) Latest Closing Stock Price
Jaguar Health, Inc. (JAGX) last closed at $2.63 as of 2026-10-22 00:00:00, unchanged from the previous close of $2.63.
During the latest regular trading session, JAGX traded between $2.25 and $1,313,490,937,500.00, with a volume of 476.43K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Jaguar Health, Inc. (JAGX) 7-Day Stock Price Change
Over the past seven days, Jaguar Health, Inc. (JAGX) moved from $4.16 to $2.27, representing a decline of 45.43% ($1.89).
The stock traded between $2.25 and $4.65 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 618.09 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
JAGX 52-Week Price Position
Position in Range: 0.0%
JAGX is currently trading at $2.27, placing it 0.0% of the way from its 52-week low of $2.25 to its 52-week high of $1,118.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Jaguar Health, Inc. (JAGX)?
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Jaguar Health, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 47 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Jaguar Health, Inc. (JAGX) Stock on MEXC
Eligible investors can buy real shares of Jaguar Health, Inc. (JAGX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Jaguar Health, Inc. (JAGX) stock price today?
2.Is JAGX stock going up or down today?
3.What is JAGX pre-market price?
4.What is JAGX after-hours price?
5.Is JAGX stock trading now?
6.Where does JAGX sit relative to its 52-week high and low?
7.What sector is Jaguar Health, Inc. in?
8.What is Jaguar Health, Inc.'s market capitalization and where is it listed?
9.How is JAGX valued in terms of P/E ratio and EPS?
10.Does Jaguar Health, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
JAGX Stock Calculator
Estimate the value between JAGX shares and USD.
JAGX Shares to USD
1.00 JAGX shares = 2.27 USD
Calculations are estimates based on the latest available price and are for reference only.


